Common mental disorders in irritable bowel syndrome: pathophysiology, management, and considerations for future randomised controlled trials

RECOMMENDED

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial

★ 2 Recommended by Prof. Dr Stephan Vavricka, Faculty Member

doi: 10.1016/S2468-1253(20)30056-X.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial

Lancet Gastroenterol Hepatol.

Aroniadis OC, Brandt LJ, Oneto C, Feuerstadt P, Sherman A, Wolkoff AW, Kassam Z, Sadovsky RG, Elliott RJ, Budree S, Kim M, Keller MJ

doi: 10.1016/S2468-1253

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Randomised clinical trial: pregabalin vs placebo for irritable bowel syndrome

Aliment Pharmacol Ther.

Saito YA, Almazar AE, Tilkes KE, Choung RS, Van Norstrand MD, Schleck CD, Zinsmeister AR, Talley NJ

doi: 10.1111/apt.15077.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: a systematic review and meta-analysis of randomized controlled trials

Am J Clin Nutr.

Wilson B, Rossi M, Dimidi E, Whelan K

doi: 10.1093/ajcn/nqy376.

Inflammatory Bowel Disease

Comparison of the metabolomic profiles of irritable bowel syndrome patients with ulcerative colitis patients and healthy controls: new insights into pathophysiology and potential biomarkers

Aliment Pharmacol Ther.

Keshteli AH, Madsen KL, Mandal R, Boeckxstaens GE, Bercik P, De Palma G, Reed DE, Wishart D, Vanner S, Dieleman LA

doi: 10.1111/apt.15141.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial

Lancet Gastroenterol Hepatol.

Everitt HA, Landau S, O'Reilly G, Sibelli A, Hughes S, Windgassen S, Holland R, Little P, McCrone P, Bishop FL, Goldsmith K, Coleman N, Logan R, Chalder T, Moss-Morris R

doi: 10.1016/S2468-1253(19)30243-2.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Group cognitive behavioural therapy (GCBT) versus treatment as usual (TAU) in the treatment of irritable bowel syndrome (IBS): a study protocol for a randomized controlled trial

BMC Gastroenterol.

Kikuchi S, Oe Y, Sasaki Y, Ishii H, Ito Y, Horikoshi M, Sozu T, Seno H, Furukawa TA

doi: 10.1186/s12876-020-1157-z.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study

Gut.

El-Salhy M, Hatlebakk JG, Gilja OH, Bråthen Kristoffersen A, Hausken T

doi: 10.1136/gutjnl-2019-319630.

Gastroesophageal Reflux Disease (GERD)

Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders

Ann Gastroenterol.

de Bortoli N, Tolone S, Frazzoni M, Martinucci I, Sgherri G, Albano E, Ceccarelli L, Stasi C, Bellini M, Savarino V, Savarino EV, Marchi S

doi: 10.20524/aog.2018.0314.

Related content

Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial

Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial

Randomised clinical trial: pregabalin vs placebo for irritable bowel syndrome

Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: a systematic review and meta-analysis of randomized controlled trials

Comparison of the metabolomic profiles of irritable bowel syndrome patients with ulcerative colitis patients and healthy controls: new insights into pathophysiology and potential biomarkers

Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial

Group cognitive behavioural therapy (GCBT) versus treatment as usual (TAU) in the treatment of irritable bowel syndrome (IBS): a study protocol for a randomized controlled trial

Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study

Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders